Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 Jun;63(6):1205-11.
doi: 10.1161/HYPERTENSIONAHA.114.03231. Epub 2014 Mar 24.

Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk

Affiliations
Multicenter Study

Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk

Jenifer M Brown et al. Hypertension. 2014 Jun.

Abstract

Aging and abnormal aldosterone regulation are both associated with vascular disease. We hypothesized that aldosterone dysregulation influences the age-related risk of renal vascular and cardiovascular disease. We conducted an analysis of 562 subjects who underwent detailed investigations under conditions of liberal and restricted dietary sodium intake (1124 visits) in the General Clinical Research Center. Aldosterone regulation was characterized by the ratio of maximal suppression to stimulation (supine serum aldosterone on a liberal sodium diet divided by the same measure on a restricted sodium diet). We previously demonstrated that higher levels of this Sodium-modulated Aldosterone Suppression-Stimulation Index (SASSI) indicate greater aldosterone dysregulation. Renal plasma flow (RPF) was determined via p-aminohippurate clearance to assess basal renal hemodynamics and the renal vascular responses to dietary sodium manipulation and angiotensin II infusion. Cardiovascular risk was calculated using the Framingham Risk Score. In univariate linear regression, older age (β=-4.60; P<0.0001) and higher SASSI (β=-58.63; P=0.001) predicted lower RPF and a blunted RPF response to sodium loading and angiotensin II infusion. We observed a continuous, independent, multivariate-adjusted interaction between age and SASSI, where the inverse relationship between SASSI and RPF was most apparent with older age (P<0.05). Higher SASSI and lower RPF independently predicted higher Framingham Risk Score (P<0.0001) and together displayed an additive effect. Aldosterone regulation and age may interact to mediate renal vascular disease. Our findings suggest that the combination of aldosterone dysregulation and renal vascular dysfunction could additively increase the risk of future cardiovascular outcomes; therefore, aldosterone dysregulation may represent a modifiable mechanism of age-related vascular disease.

Keywords: aging; aldosterone; renal plasma flow; renin-angiotensin system.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST/DISCLOSURES: None.

Figures

Figure 1
Figure 1. Interaction between age and SASSI predicts renal plasma flow (RPF)
For every quartile of aldosterone dysregulation (SASSI), we observe an inverse relationship between age and renal-vascular function. In contrast, in the younger age quartiles (Q1-Q2), RPF is relatively independent of SASSI, whereas with older age (Q3-Q4), there is an increasingly apparent negative relationship between SASSI and renal-vascular function. In an adjusted, continuous, interaction model, there was a significant interaction between age and SASSI in predicting RPF (p-interaction<0.027), suggesting that aldosterone dysregulation may modify the effect of age on renal-vascular function.
Figure 2
Figure 2. Aldosterone dysregulation and impaired renal-vascular hemodynamics may additively contribute to CVD risk
Higher SASSI and lower Renal Plasma Flow (RPF) appear to display an additive effect in predicting Framingham Risk Score (FRS), such that higher SASSI in combination with lower RPF correspond to the highest FRS. Q1-Q4 indicate quartiles 1-4 of RPF and of SASSI.

References

    1. Yoshimoto T, Hirata Y. Aldosterone as a cardiovascular risk hormone. Endocr J. 2007;54:359–370. - PubMed
    1. Rossi G, Boscaro M, Ronconi V, Funder JW. Aldosterone as a cardiovascular risk factor. Trends Endocrinol Metab. 2005;16:104–107. - PubMed
    1. Nishimura M, Uzu T, Fujii T, Kuroda S, Nakamura S, Inenaga T, Kimura G. Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis. 1999;33:261–266. - PubMed
    1. Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: Cardiovascular, renal and metabolic implications. Trends Endocrinol Metab. 2008;19:88–90. - PubMed
    1. Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Catena C. Long-term renal outcomes in patients with primary aldosteronism. JAMA. 2006;295:2638–2645. - PubMed

Publication types

MeSH terms

LinkOut - more resources